Publications by authors named "Julia Beutel"

Claim this Profile
B
Bevacizumab as adjuvant for neovascular glaucoma.
Julia Beutel, Swaantje Peters, Matthias Lüke, Sabin Aisenbrey, Peter Szurman

Acta Ophthalmol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravitreal bevacizumab treatment of macular edema in central retinal vein occlusion: one-year results.
Julia Beutel, Focke Ziemssen, Matthias Lüke, Michael Partsch, Karl-Ulrich Bartz-Schmidt

Int Ophthalmol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible implications of MCAM expression in metastasis and non-metastatic of primary uveal melanoma patients.
Julia Beutel, Jürgen Wegner, Rayime Wegner, Focke Ziemssen, Khaled Nassar

Curr Eye Res· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full macular translocation (FMT) versus photodynamic therapy (PDT) with verteporfin in the treatment of neovascular age-related macular degeneration: 2-year results of a prospective, controlled, randomised pilot trial (FMT-PDT).
Matthias Lüke, Focke Ziemssen, Michael Völker, Elke Altpeter, Julia Beutel

Graefes Arch Clin Exp Ophthalmol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and future therapies for age-related macular degeneration.
Julia Beutel, Martin Rudolf, Salvatore Grisanti

Expert Opin Emerg Drugs· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of triamcinolone crystals on retinal function in a model of isolated perfused vertebrate retina.
Matthias Lüke, Kai Januschowski, Julia Beutel, Max Warga, Salvatore Grisanti

Exp Eye Res· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visualization of circulating melanoma cells in peripheral blood of patients with primary uveal melanoma.
Anja Ulmer, Julia Beutel, Daniela Süsskind, Ralf-Dieter Hilgers, Focke Ziemssen

Clin Cancer Res· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrophysiological effects of Brilliant Blue G in the model of the isolated perfused vertebrate retina.
Matthias Lüke, Kai Januschowski, Julia Beutel, Christoph Lüke, Salvatore Grisanti

Graefes Arch Clin Exp Ophthalmol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety monitoring in bevacizumab (Avastin) treatment: retinal function assessed by psychophysical (visual fields, colour vision) and electrophysiological (ERG/EOG) tests in two subgroups of patients.
Focke Ziemssen, Matthias Lüke, Andre Messias, Julia Beutel, Olcay Tatar

Int Ophthalmol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inner limiting membrane as membranous support in RPE sheet-transplantation.
Julia Beutel, Lena Greulich, Matthias Lüke, Focke Ziemssen, Peter Szurman

Graefes Arch Clin Exp Ophthalmol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological prevention of radiation-induced dry eye-an experimental study in a rabbit model.
Julia Beutel, Christina Schroder, Katharina von Hof, Dirk Rades, Hartwig Kosmehl

Graefes Arch Clin Exp Ophthalmol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The retinal tolerance to bevacizumab in co-application with a recombinant tissue plasminogen activator.
Matthias Lüke, Kai Januschowski, Max Warga, Julia Beutel, Martin Leitritz

Br J Ophthalmol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Internal limiting membrane peeling with indocyanine green or trypan blue in macular hole surgery: a randomized trial.
Julia Beutel, Gerlinde Dahmen, Andreas Ziegler, Hans Hoerauf

Arch Ophthalmol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis